Literature DB >> 7926742

The POP1 gene encodes a protein component common to the RNase MRP and RNase P ribonucleoproteins.

Z Lygerou1, P Mitchell, E Petfalski, B Séraphin, D Tollervey.   

Abstract

Two forms of the yeast 5.8S rRNA are generated from a large precursor by distinct processing pathways. Cleavage at site A3 is required for synthesis of the major, short form, designated 5.8S(S), but not for synthesis of the long form, 5.8S(L). To identify components required for A3 cleavage, a bank of temperature-sensitive lethal mutants was screened for those with a reduced ratio of 5.8S(S):5.8S(L). The pop1-1 mutation (for processing of precursor RNAs) shows this phenotype and also inhibits A3 cleavage. The pre-rRNA processing defect of pop1-1 strains is similar to that reported for mutations in the RNA component of RNase MRP; we show that a mutation in the RNase MRP RNA also inhibits cleavage at site A3. This is the first site shown to require RNase MRP for cleavage in vivo. The pop1-1 mutation also leads to a block in the processing of pre-tRNA that is identical to that reported for mutations in the RNA component of RNase P. The RNA components of both RNase MRP and RNase P are underaccumulated in pop1-1 strains at the nonpermissive temperature, and immunoprecipitation demonstrates that POP1p is a component of both ribonucleoproteins. The POP1 gene encodes a protein with a predicted molecular mass of 100.5 kD and is essential for viability. POP1p is the first protein component of the nuclear RNase P or RNase MRP for which the gene has been cloned.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7926742     DOI: 10.1101/gad.8.12.1423

Source DB:  PubMed          Journal:  Genes Dev        ISSN: 0890-9369            Impact factor:   11.361


  115 in total

1.  Sm and Sm-like proteins assemble in two related complexes of deep evolutionary origin.

Authors:  J Salgado-Garrido; E Bragado-Nilsson; S Kandels-Lewis; B Séraphin
Journal:  EMBO J       Date:  1999-06-15       Impact factor: 11.598

Review 2.  Protein trans-acting factors involved in ribosome biogenesis in Saccharomyces cerevisiae.

Authors:  D Kressler; P Linder; J de La Cruz
Journal:  Mol Cell Biol       Date:  1999-12       Impact factor: 4.272

3.  Degradation of ribosomal RNA precursors by the exosome.

Authors:  C Allmang; P Mitchell; E Petfalski; D Tollervey
Journal:  Nucleic Acids Res       Date:  2000-04-15       Impact factor: 16.971

4.  Defects in tRNA processing and nuclear export induce GCN4 translation independently of phosphorylation of the alpha subunit of eukaryotic translation initiation factor 2.

Authors:  H Qiu; C Hu; J Anderson; G R Björk; S Sarkar; A K Hopper; A G Hinnebusch
Journal:  Mol Cell Biol       Date:  2000-04       Impact factor: 4.272

Review 5.  Eukaryotic ribonuclease P: increased complexity to cope with the nuclear pre-tRNA pathway.

Authors:  S Xiao; F Houser-Scott; D R Engelke
Journal:  J Cell Physiol       Date:  2001-04       Impact factor: 6.384

6.  RNA-protein interactions in the human RNase MRP ribonucleoprotein complex.

Authors:  H Pluk; H van Eenennaam; S A Rutjes; G J Pruijn; W J van Venrooij
Journal:  RNA       Date:  1999-04       Impact factor: 4.942

7.  Nop58p is a common component of the box C+D snoRNPs that is required for snoRNA stability.

Authors:  D L Lafontaine; D Tollervey
Journal:  RNA       Date:  1999-03       Impact factor: 4.942

8.  Basic domains target protein subunits of the RNase MRP complex to the nucleolus independently of complex association.

Authors:  H van Eenennaam; A van der Heijden; R J Janssen; W J van Venrooij; G J Pruijn
Journal:  Mol Biol Cell       Date:  2001-11       Impact factor: 4.138

9.  Function and subnuclear distribution of Rpp21, a protein subunit of the human ribonucleoprotein ribonuclease P.

Authors:  N Jarrous; R Reiner; D Wesolowski; H Mann; C Guerrier-Takada; S Altman
Journal:  RNA       Date:  2001-08       Impact factor: 4.942

Review 10.  Eukaryotic ribonuclease P: a plurality of ribonucleoprotein enzymes.

Authors:  Shaohua Xiao; Felicia Scott; Carol A Fierke; David R Engelke
Journal:  Annu Rev Biochem       Date:  2001-11-09       Impact factor: 23.643

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.